In germline TP53 pathogenic variant carriers, breast cancer risk increases significantly after the second decade, rises up to 20%–30% under the age 31, reaches a peak between 25–35 years and drops after 40 years of age, while the cumulative risk reaches a plateau before 60 (23). This evidence concerns the gene TP53 and breast carcinoma.